0001104659-20-031954.txt : 20200311
0001104659-20-031954.hdr.sgml : 20200311
20200311163036
ACCESSION NUMBER: 0001104659-20-031954
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200311
DATE AS OF CHANGE: 20200311
EFFECTIVENESS DATE: 20200311
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-362571
FILM NUMBER: 20705645
BUSINESS ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
D
1
primary_doc.xml
X0708
D
LIVE
0001541157
Akari Therapeutics Plc
75/76 WIMPOLE STREET
LONDON
X0
UNITED KINGDOM
W1G 9RT
+44 20 8004 0270
UNITED KINGDOM
None
Celsus Therapeutics Plc.
Morria Biopharmaceuticals PLC
Corporation
true
Clive
Richardson
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Executive Officer
Director
Peter
Feldschreiber
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
Ray
Prudo
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
James
Hill
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
Stuart
Ungar
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
David
Byrne
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
Donald
Williams
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
Michael
Grissinger
c/o Akari Therapeutics, PLC
75/76 Wimpole Street
London
X0
UNITED KINGDOM
W1G 9RT
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-02-13
false
true
true
false
0
Paulson Investment Company, LLC
5670
None
None
2141 W. NORTH AVE.
2ND FLOOR
CHICAGO
IL
ILLINOIS
60647
CA
CALIFORNIA
CT
CONNECTICUT
FL
FLORIDA
GA
GEORGIA
HI
HAWAII
ID
IDAHO
IL
ILLINOIS
IN
INDIANA
MD
MARYLAND
MI
MICHIGAN
NJ
NEW JERSEY
NM
NEW MEXICO
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OK
OKLAHOMA
OR
OREGON
PA
PENNSYLVANIA
TX
TEXAS
VA
VIRGINIA
WI
WISCONSIN
WY
WYOMING
true
9554528
9554528
0
false
53
764362
0
449,623 placement agent warrants
0
Working capital purposes
false
Akari Therapeutics Plc
/s/ Clive Richardson
Clive Richardson
Chief Executive Officer and Chief Operating Officer
2020-03-11